1. Cyclophosphamide and cisplatin comparedn with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer;McGuire;N Engl J Med,1996
2. Randomized intergroup trial of cisplatin–paclitaxel versus cisplatin–cyclophosphamide in women with advanced epithelial ovarian cancer;Piccart;J Natl Cancer Inst,2000
3. Ozols RF, Bundy BN, Fowler J, Clarke-Pearson D, Mannel R, Hartenbach EM, Baergen R, GOG Philadelphia, PA. Randomized phase III study of cisplatin (CIS)/paclitaxel (PAC) versus carboplatin (CARBO)/PAC in optimal stage ill epithelial ovarian cancer (OC): a Gynecologic Oncology Group trial (GOG 158). Proc Am Soc Clin Oncol 1999;18:1373
4. AGO Ovarian Cancer Study Group, Department of Gynecology St. Vincentius KHS, Karlsruhe, Germany;Du Bois;Proc Am Soc Clin Oncol,1999
5. Responses to salvage chemotherapy in ovarian cancer;Markman;J Clin Oncol,1992